Center-Authored Papers

Filters: Author is Wactawski-Wende, Jean  [Clear All Filters]
Journal Article
Chlebowski RT, Johnson KC, Lane D, Pettinger M, Kooperberg C, Wactawski-Wende J, Rohan T, O'Sullivan MJ, Yasmeen S, Hiatt RA et al..  2011.  25-hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women.. Maturitas. 68(1):73-8. Abstract
Klein AP, Lindström S, Mendelsohn JB, Steplowski E, Arslan AA, Bueno-de-Mesquita BH, Fuchs CS, Gallinger S, Gross M, Helzlsouer K et al..  2013.  An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population.. PloS one. 8(9):e72311. Abstract
Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, Lessin L, O'Sullivan MJ, Wactawski-Wende J, Yasmeen S et al..  2010.  Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.. Journal of the National Cancer Institute. 102(18):1422-31. Abstract
Michaud DS, Vrieling A, Jiao L, Mendelsohn JB, Steplowski E, Lynch SM, Wactawski-Wende J, Arslan AA, Bas Bueno-de-Mesquita H, Fuchs CS et al..  2010.  Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan).. Cancer causes & control : CCC. 21(8):1213-25. Abstract
Sampson JN, Wheeler WA, Yeager M, Panagiotou O, Wang Z, Berndt SI, Lan Q, Abnet CC, Amundadottir LT, Figueroa JD et al..  2015.  Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.. Journal of the National Cancer Institute. 107(12) Abstract
Oh H, Coburn SB, Matthews CE, Falk RT, Leblanc ES, Wactawski-Wende J, Sampson J, Pfeiffer RM, Brinton LA, Wentzensen N et al..  2017.  Anthropometric measures and serum estrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study.. Breast cancer research : BCR. 19(1):28. Abstract
Brasky TM, White E, Wactawski-Wende J.  2016.  Aspirin and Cancer Risk.. JAMA oncology.
Zaslavsky O, Rillamas-Sun E, LaCroix AZ, Woods NF, Tinker LF, Zisberg A, Shadmi E, Cochrane B, Edward BJ, Kritchevsky S et al..  2016.  Association Between Anthropometric Measures and Long-Term Survival in Frail Older Women: Observations from the Women's Health Initiative Study.. Journal of the American Geriatrics Society. 64(2):277-84. Abstract
Coghill AE, Phipps AI, Bavry AA, Wactawski-Wende J, Lane DS, Lacroix A, Newcomb PA.  2012.  The Association between NSAID use and Colorectal Cancer Mortality: Results from the Women's Health Initiative.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(11):1966-73. Abstract
Ochs-Balcom HM, Preus L, Wactawski-Wende J, Nie J, Johnson NA, Zakharia F, Tang H, Carlson C, Carty C, Chen Z et al..  2013.  Association of DXA-derived Bone Mineral Density and Fat Mass With African Ancestry.. The Journal of clinical endocrinology and metabolism. 98(4):E713-7. Abstract
Crandall CJ, Manson JE, Hohensee C, Horvath S, Wactawski-Wende J, Leblanc ES, Vitolins MZ, Nassir R, Sinsheimer JS.  2017.  Association of genetic variation in the tachykinin receptor 3 locus with hot flashes and night sweats in the Women's Health Initiative Study.. Menopause (New York, N.Y.). 24(3):252-261. Abstract
Crandall CJ, Aragaki A, Cauley JA, Manson JE, Leblanc E, Wallace R, Wactawski-Wende J, Lacroix A, O'Sullivan MJ, Vitolins M et al..  2015.  Associations of menopausal vasomotor symptoms with fracture incidence.. The Journal of clinical endocrinology and metabolism. 100(2):524-34. Abstract
Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J et al..  2009.  Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.. American journal of epidemiology. 170(1):12-23. Abstract
Arem H, Chlebowski R, Stefanick ML, Anderson G, Wactawski-Wende J, Sims S, Gunter MJ, Irwin ML.  2013.  Body mass index, physical activity, and survival after endometrial cancer diagnosis: Results from the Women's Health Initiative.. Gynecologic oncology. 128(2):181-86. Abstract
Phipps AI, Chlebowski RT, Prentice RL, McTiernan A, Stefanick ML, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Vitolins M et al..  2011.  Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(3):454-63. Abstract
Chlebowski RT, Rohan TE, Manson JE, Aragaki AK, Kaunitz A, Stefanick ML, Simon MS, Johnson KC, Wactawski-Wende J, O'Sullivan MJ et al..  2015.  Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.. JAMA oncology. 1(3):296-305. Abstract
Crandall CJ, Aragaki AK, Cauley JA, McTiernan A, Manson JE, Anderson GL, Wactawski-Wende J, Chlebowski RT.  2012.  Breast tenderness after initiation of conjugated equine estrogens and mammographic density change.. Breast cancer research and treatment. 131(3):969-979. Abstract
Cauley JA, Chlebowski RT, Wactawski-Wende J, Robbins JA, Rodabough RJ, Chen Z, Johnson KC, O'Sullivan MJ, Jackson RD, Manson JE.  2013.  Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative.. Journal of women's health (2002). 22(11):915-29. Abstract
Crandall CJ, Aragaki AK, LeBoff MS, Li W, Wactawski-Wende J, Cauley JA, Margolis KL, Manson JE.  2016.  Calcium plus vitamin D supplementation and height loss: findings from the Women's Health Initiative Calcium and Vitamin D clinical trial.. Menopause (New York, N.Y.). 23(12):1277-1286. Abstract
Chlebowski RT, Pettinger M, Johnson KC, Wallace R, Womack C, Mossavar-Rahmani Y, Stefanick M, Wactawski-Wende J, Carbone L, Lu B et al..  2013.  Calcium Plus Vitamin D Supplementation and Joint Symptoms in Postmenopausal Women in the Women's Health Initiative Randomized Trial.. Journal of the Academy of Nutrition and Dietetics. 113(10):1302-10. Abstract
Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S et al..  2008.  Calcium plus vitamin D supplementation and the risk of breast cancer.. Journal of the National Cancer Institute. 100(22):1581-91. Abstract
Bea JW, Thomson CA, Wallace RB, Wu C, Seguin RA, Going SB, Lacroix A, Eaton C, Ockene JK, Lamonte MJ et al..  2016.  Changes in Physical Activity, Sedentary Time, and Risk of Falling: The Women's Health Initiative Observational Study.. Preventive medicine. Abstract
Prentice RL, Pettinger M, Beresford SAA, Wactawski-Wende J, Hubbell AF, Stefanick ML, Chlebowski RT.  2009.  Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(5):1531-7. Abstract
Crandall CJ, Hovey KM, Andrews C, Cauley JA, Stefanick M, Shufelt C, Prentice RL, Kaunitz AM, Eaton C, Wactawski-Wende J et al..  2017.  Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study.. Menopause (New York, N.Y.). Abstract
Anderson GL, Chlebowski RT, Aragaki AK, Kuller LH, Manson JE, Gass M, Bluhm E, Connelly S, Hubbell AF, Lane D et al..  2012.  Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.. The lancet oncology. 13(5):476-486. Abstract